World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
17307
World Ranking
1937
National Ranking
945

Medicine

D-Index
76
Citations
17279
World Ranking
18921
National Ranking
9431

Robert H. Wiltrout publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert H. Wiltrout sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 269 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert H. Wiltrout D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert H. Wiltrout sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert H. Wiltrout is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on the fields of Biochemistry, Genetics, and Molecular Biology, contributing to a total of three publications within these domains.

The scientist has concentrated their work on subfields such as Cancer Research and Molecular Biology, with two publications relating to cancer research and one to molecular biology. Their main topics of study include Cancer, Lipids, and Metabolism; Metabolomics and Mass Spectrometry Studies; and Cancer, Hypoxia, and Metabolism, with two publications covering each of these topics.

Among recent publications, Robert H. Wiltrout authored a paper titled "Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma", published in 2021 in the journal Scientific Reports.

Frequent coauthors of Robert H. Wiltrout include:

  • Yotsawat Pomyen
  • Anuradha Budhu
  • Jittiporn Chaisaingmongkol
  • Marshonna Forgues
  • Hien Dang

Scientific Reports is the primary venue for their published work, with one publication in this journal.

Best Publications

  • Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis

    Mark J. Smyth;Erika Cretney;Kazuyoshi Takeda;Robert H. Wiltrout

  • Loss of T-Cell Receptor ζ Chain and p56lck in T-Cells Infiltrating Human Renal Cell Carcinoma

    James H. Finke;Arnold H. Zea;Jill Stanley;Dan L. Longo

  • Role of NK cells in the control of metastatic spread and growth of tumor cells in mice

    E. Gorelik;R. H. Wiltrout;K. Okumura;S. Habu

  • IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

    Tomoaki Hoshino;Robert H. Wiltrout;Howard A. Young

  • The CD95 receptor: apoptosis revisited.

    Marcus E. Peter;Ralph C. Budd;Julie Desbarats;Stephen M. Hedrick

  • Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma

    Jittiporn Chaisaingmongkol;Jittiporn Chaisaingmongkol;Anuradha Budhu;Hien Dang;Siritida Rabibhadana

  • Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

    Shivaani Kummar;Robert Kinders;Martin E. Gutierrez;Larry Rubinstein

  • Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

    T Barlozzari;J Leonhardt;R H Wiltrout;R B Herberman

  • Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

    R. H. Wiltrout;R. B. Herberman;Shu-Ren Zhang;M. A. Chirigos

  • The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

    Jeffrey E Green;Masa-Aki Shibata;Katsuhide Yoshidome;Min-ling Liu

  • Immunotherapy of cancer by IL-12-based cytokine combinations.

    Jonathan M Weiss;Jeff J Subleski;Jon M Wigginton;Robert H Wiltrout

  • Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

    William J Murphy;Lisbeth A. Welniak;Dennis D. Taub;Robert H. Wiltrout

  • Compressing drug development timelines in oncology using phase '0' trials.

    Shivaani Kummar;Robert Kinders;Larry Rubinstein;Ralph E. Parchment

  • In vivo administration of IL‐18 can induce IgE production through Th2 cytokine induction and up‐regulation of CD40 ligand (CD154) expression on CD4+ T cells

    Tomoaki Hoshino;Hideo Yagita;John R. Ortaldo;Robert H. Wiltrout

  • Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

    Robert H. Wiltrout;Bonnie J. Mathieson;James E. Talmadge;Craig W. Reynolds

  • Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood

    Xin Chen;Jeffrey J. Subleski;Ryoko Hamano;O. M. Zack Howard

  • IFN-γ mediates CD4 + T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

    Vanessa Berner;Haiyan Liu;Qing Zhou;Kory L Alderson

  • Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth.

    Paritosh Ghosh;Kristin L. Komschlies;Marco Cippitelli;Dan L. Longo

  • Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice

    James E. Talmadge;Henry R. Tribble;Robin W. Pennington;Hamblin Phillips

  • Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal Carcinoma

    Jon M. Wigginton;Kristin L. Komschlies;Timothy C. Back;José L. Franco

Frequent Co-Authors

John R. Ortaldo
John R. Ortaldo National Institutes of Health
William J. Murphy
William J. Murphy Texas A&M University
Dan L. Longo
Dan L. Longo Harvard University
Jon M. Wigginton
Jon M. Wigginton Bristol-Myers Squibb (Germany)
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Thomas J. Sayers
Thomas J. Sayers Leidos (United States)
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
Howard A. Young
Howard A. Young National Institutes of Health
Francis W. Ruscetti
Francis W. Ruscetti National Institutes of Health
Dennis D. Taub
Dennis D. Taub George Washington University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various advanced healthcare careers, many of which intersect with nursing specialties. For professionals already in nursing, transitioning to specialized roles such as an Acute Care Nurse Practitioner can be streamlined through options like the fnp to acute care np bridge program. This pathway helps expand expertise in patient care, especially for immunocompromised individuals.

For those starting their healthcare education, accelerated options are available. The accelerated np programs cater to individuals with prior degrees seeking to fast-track their Nurse Practitioner credentials, a vital role in disease management and immunology-related care.

Non-nurses interested in entering the healthcare field may consider foundational programs such as online adn programs for non nurses. These degrees provide essential knowledge and clinical skills relevant to immunology and patient care.

Career advancement in nursing specialties often correlates with remuneration. Exploring details about dnp salary by specialty can guide students and professionals in making informed decisions about their educational investments and career goals within immunology and related fields.

Best Scientists Citing Robert H. Wiltrout

Trending Scientists

Recently Published Articles